Mergers & Acquisitions
Oct. 7, 2014
Dealmakers
A roundup of recent M&A, IPO and financing deals and the lawyers involved.
Latham reps Alios in sale to J&J
Latham & Watkins LLP represented San Francisco-based drugmaker Alios BioPharma Inc. in its $1.75 billion sale to Johnson & Johnson in a deal announced Sept. 30.
Alios, which develops antiviral drugs, is currently in Phase 2 trials for a compound intended to treat infants with respiratory syncytial virus, or RSV.
Menlo Park partner Mark V. Roeder and associate Chad G. Rolston led the...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In